These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 32662404)

  • 1. One year in review 2020: systemic sclerosis.
    Orlandi M; Lepri G; Damiani A; Barsotti S; Di Battista M; Codullo V; Della Rossa A; Guiducci S; Allanore Y
    Clin Exp Rheumatol; 2020; 38 Suppl 125(3):3-17. PubMed ID: 32662404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic sclerosis: one year in review 2022.
    Lepri G; Orlandi M; Di Battista M; De Mattia G; Da Rio M; Codullo V; Guiducci S; Della Rossa A
    Clin Exp Rheumatol; 2022 Oct; 40(10):1911-1920. PubMed ID: 36135958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One year in review 2019: systemic sclerosis.
    Barsotti S; Orlandi M; Codullo V; Di Battista M; Lepri G; Della Rossa A; Guiducci S
    Clin Exp Rheumatol; 2019; 37 Suppl 119(4):3-14. PubMed ID: 31587697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic sclerosis in adults. Part I: Clinical features and pathogenesis.
    Jerjen R; Nikpour M; Krieg T; Denton CP; Saracino AM
    J Am Acad Dermatol; 2022 Nov; 87(5):937-954. PubMed ID: 35131402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic sclerosis: Recent insight in clinical management.
    Zanatta E; Codullo V; Avouac J; Allanore Y
    Joint Bone Spine; 2020 Jul; 87(4):293-299. PubMed ID: 31568838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One year in review 2018: systemic sclerosis.
    Orlandi M; Barsotti S; Lepri G; Codullo V; Di Battista M; Guiducci S; Della Rossa A
    Clin Exp Rheumatol; 2018; 36 Suppl 113(4):3-23. PubMed ID: 30277868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender-related differences in systemic sclerosis.
    Hughes M; Pauling JD; Armstrong-James L; Denton CP; Galdas P; Flurey C
    Autoimmun Rev; 2020 Apr; 19(4):102494. PubMed ID: 32062031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One year in review 2016: systemic sclerosis.
    Barsotti S; Stagnaro C; d'Ascanio A; Della Rossa A
    Clin Exp Rheumatol; 2016; 34 Suppl 100(5):3-13. PubMed ID: 27463613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic sclerosis and cryoglobulinemia: our experience with overlapping syndrome of scleroderma and severe cryoglobulinemic vasculitis and review of the literature.
    Giuggioli D; Manfredi A; Colaci M; Manzini CU; Antonelli A; Ferri C
    Autoimmun Rev; 2013 Sep; 12(11):1058-63. PubMed ID: 23806565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidences and Risk Factors of Organ Manifestations in the Early Course of Systemic Sclerosis: A Longitudinal EUSTAR Study.
    Jaeger VK; Wirz EG; Allanore Y; Rossbach P; Riemekasten G; Hachulla E; Distler O; Airò P; Carreira PE; Balbir Gurman A; Tikly M; Vettori S; Damjanov N; Müller-Ladner U; Distler JH; Li M; Walker UA;
    PLoS One; 2016; 11(10):e0163894. PubMed ID: 27706206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early inflammatory players in cutanous fibrosis.
    Raker V; Haub J; Stojanovic A; Cerwenka A; Schuppan D; Steinbrink K
    J Dermatol Sci; 2017 Sep; 87(3):228-235. PubMed ID: 28655471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel multi-network approach reveals tissue-specific cellular modulators of fibrosis in systemic sclerosis.
    Taroni JN; Greene CS; Martyanov V; Wood TA; Christmann RB; Farber HW; Lafyatis RA; Denton CP; Hinchcliff ME; Pioli PA; Mahoney JM; Whitfield ML
    Genome Med; 2017 Mar; 9(1):27. PubMed ID: 28330499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Systemic sclerosis--clinical course and treatment possibilities].
    Szymańska E; Maj M; Rudnicka L
    Przegl Lek; 2005; 62(12):1538-41. PubMed ID: 16786791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Animal models in systemic sclerosis: an update.
    Bi X; Mills T; Wu M
    Curr Opin Rheumatol; 2023 Nov; 35(6):364-370. PubMed ID: 37605874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune cell dysregulation as a mediator of fibrosis in systemic sclerosis.
    Fang D; Chen B; Lescoat A; Khanna D; Mu R
    Nat Rev Rheumatol; 2022 Dec; 18(12):683-693. PubMed ID: 36352098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Current treatment of systemic scleroderma].
    Hunzelmann N
    Hautarzt; 2018 Nov; 69(11):901-907. PubMed ID: 30143809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on biomarkers in systemic sclerosis: tools for diagnosis and treatment.
    Affandi AJ; Radstake TR; Marut W
    Semin Immunopathol; 2015 Sep; 37(5):475-87. PubMed ID: 26168983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interstitial lung disease in systemic sclerosis.
    Renzoni EA
    Monaldi Arch Chest Dis; 2007 Dec; 67(4):217-28. PubMed ID: 18309700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paquinimod reduces skin fibrosis in tight skin 1 mice, an experimental model of systemic sclerosis.
    Stenström M; Nyhlén HC; Törngren M; Liberg D; Sparre B; Tuvesson H; Eriksson H; Leanderson T
    J Dermatol Sci; 2016 Jul; 83(1):52-9. PubMed ID: 27156795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insights into the knowledge of complex diseases: Environmental infectious/toxic agents as potential etiopathogenetic factors of systemic sclerosis.
    Ferri C; Arcangeletti MC; Caselli E; Zakrzewska K; Maccari C; Calderaro A; D'Accolti M; Soffritti I; Arvia R; Sighinolfi G; Artoni E; Giuggioli D
    J Autoimmun; 2021 Nov; 124():102727. PubMed ID: 34601207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.